DUBLIN--(BUSINESS WIRE)--Sep 22, 2022--
The "Global Cancer Gene Therapy Market Research and Forecast 2022-2028" report has been added to ResearchAndMarkets.com's offering.
The global cancer gene therapy market is anticipated to grow at a substantial CAGR of 23.1% during the forecast period. One of the major factors that are fueling the market includes the rising pool of population with cancer patients coupled with an increasing geriatric population base. Globally there is a rise in cancer patients each year.
Several initiatives are being launched about gene therapy catering to treating and reducing the number of cancer incidences across the globe. For instance, in October 2021, the National Institutes of Health, the US Food and Drug Administration (US FDA), ten pharmaceutical companies, and five non-profit groups have teamed up to speed up gene therapy development for the 30 million Americans who suffer from a rare disease.
Such measures are expected to boost demand for gene therapy, boosting the market growth. Additionally, in October 2019, GammaDelta Therapeutics announced the formation of the spinout company Adaptate Biotherapeutics. Adaptate develops therapeutic antibodies that can modulate the activity of gamma delta T-cells to trigger an immune response to fight cancer.
The global cancer gene therapy market can be segmented based on therapy and end-users. Based on the therapy, the cancer gene therapy market is segmented into gene transfer immunotherapy, oncolytic virotherapy, and gene-induced immunotherapy.
The gene-induced immunotherapy is further segmented as delivery of cytokines gene and delivery of tumor antigen gene. Based on end-users, the global cancer gene therapy market is diversified as hospitals, research institutes, and biotech companies. Among the therapy, the immunotherapy segment is expected to hold a considerable share in the global market owing to the rise in advancement of gene-induced immunotherapy research along with various R&D activities.
Market Segmentation
The Report Covers
Key Topics Covered:
1. Report Summary
2. Market Overview and Insights
3. Competitive Landscape
4. Market Segmentation
5. Regional Analysis
6. Company Profiles
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/vwp2vu
View source version on businesswire.com:https://www.businesswire.com/news/home/20220922005677/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH ONCOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 09/22/2022 10:13 AM/DISC: 09/22/2022 10:13 AM
http://www.businesswire.com/news/home/20220922005677/en